The correlations between CTAB and other immune biomarkers including PD-L1 assessed by RNA-seq and two additional gene expression signatures, tumor immunogenic score (TIGS) and cell proliferation (CP), were also assessed in both the discovery cohort and the TCGA cohort (Additional file 4: Fig. S4). Here, CD274 is linked to neoplasm.